Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ray D. Coakley, Hengrui Sun, Lucy A. Clunes, Julia E. Rasmussen, James R. Stackhouse, Seiko F. Okada, Ingrid Fricks, Steven L. Young, Robert Tarran
Published in Volume 118, Issue 12
J Clin Invest. 2008; 118(12):4025–4035 doi:10.1172/JCI33893
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6
E2 inhibits Ca2+ influx in airway epithelia.

Non-CF HBECs and JME CF cells were incubated with vehicle (white bars) or 10 nM E2 (black bars) unless otherwise specified. (A) Mean changes in fura-2 emission ratio in HBECs exposed to ATP (10 μM) or UDP (1 mM) ± E2 (both n = 6). (B) Mean changes in fura-2 emission ratio (340/380 nm) in non-CF HBECs (open symbols; n = 6) and CF JME cells (closed symbols; n = 4–6) exposed to 0.01–100 nM serosal E2 followed by 10 μM mucosal ATP. (C) [3H]IP release from JME cells before and after 10 μM ATP addition ± E2. (D) Mean changes in fura-2 emission ratio following 1 μM thapsigargin addition ± E2 to JME cells in a modified Ringer bath solution with 0 mM Ca2+ and 2 mM EGTA (all n = 6). (E) Mean change in fura-2 emission over time following 10 μM ATP addition in JME cells ± E2 with 2 mM external Ca2+ (n = 9). (F) Fura-2 emission over time following 10 μM ATP addition in JME cells ± E2 with 0 Ca2+ and 2 mM EGTA (n = 9). (G) Mean ISC in non-CF HBECs ± E2 (10 nM). Isc was measured following mucosal amiloride (100 μM) treatment, after which Cl secretion was elicited either with UTP (100 μM) or ionomycin (1 μM) (all n = 16). *P < 0.05 compared with control.